ArticleACS pharmacology & translational science2025
Dysbiosis-Driven Reprogramming of Secondary Bile Acid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from an
Daniel Zhi Wei Ng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.